Plandai Biotechnology Common Stock

Plandai Biotechnology (PLPL) currently reports a common stock of $4.5M as of September 2024. That compares with $820K in the prior-year period — up 447.5% year over year. Use the charts on this page to explore Plandai Biotechnology's common stock history and peer comparisons.

Plandai Biotechnology's common stock increased from $820K to $4.5M — a 447.5% year-over-year increase (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Plandai Biotechnology reported $4.5M in common stock as of September 2024. That compares with $820K in the prior-year period — up 447.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $4.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Plandai Biotechnology, and consider following PLPL for alerts when major investors trade the stock.

Plandai Biotechnology is classified in the Healthcare sector. On common stock, it currently shows $4.5M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PLPL with unrelated industries.